gadolinium dtpa has been researched along with Benign Hypothalamic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, FY; Lee, YJ; Liang, DC; Lin, JC; Shen, EY; Wong, TT | 1 |
| Finkenstaedt, M; Naul, LG | 1 |
2 other study(ies) available for gadolinium dtpa and Benign Hypothalamic Neoplasms
| Article | Year |
|---|---|
Loss of visibility of the neurohypophysis as a sign of central diabetes insipidus.
Topics: Child, Preschool; Contrast Media; Craniotomy; Diabetes Insipidus; Female; Gadolinium DTPA; Humans; Hypothalamic Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Pituitary Gland, Posterior; Teratoma; Tomography, X-Ray Computed | 1996 |
Extensive cerebrospinal fluid enhancement with gadopentetate dimeglumine in a primitive neuroectodermal tumor.
Topics: Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Child; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Female; Gadolinium DTPA; Humans; Hydrocephalus; Hypothalamic Neoplasms; Magnetic Resonance Imaging; Neuroectodermal Tumors, Primitive; Subarachnoid Space | 1997 |